Area of Focus | Biotechnology & Pharmaceutical


Biotechnology & Pharmaceutical

Experience is key. With outstanding educational and professional credentials in the life sciences and global experience in IP law, Brinks’ attorneys provide sophisticated IP services and solutions in areas including Hatch-Waxman litigation, pharmaceutical and biological client counseling, trademark analysis, pharmaceutical patent prosecution, and patent portfolio management.

Our clients range from start-ups and entrepreneurs to multinational corporations, from academic institutions to investors in technology. Our diverse backgrounds and experiences enable us to appreciate and address all of our client’s concerns, but that’s not all. What sets us even more apart is:
       Our Team: We have more than 20 experienced attorneys and patent agents in the biotechnology and pharmaceutical space with advanced qualifications, including 13 with Ph.D. degrees and nine with Master’s degrees.
  Our History: Established more than 100 years ago, Brinks has a strong history of providing highly effective legal services and obtaining IP rights for our clients that will withstand the test of time.
  Our Reputation: Brinks’ attorneys are often recognized for their excellence and professionalism in the legal industry. Most recently, 14 of our attorneys were selected to be included in “The Best Lawyers in America 2019.”

        Our Insight: With more than five attorneys with significant pharmaceutical in-house counsel experience, Brinks’ attorneys understand and tackle complex problems effectively with holistic solutions.
Our Success: Examples include:
  •    Obtained over 2,000 granted patents and filed over 3,000 patent applications in the last five years for biopharma clients

  •    Obtained a five-year patent term extension (PTE) for a client’s FDA approved drug
  •    Performed dozens of due diligence analyses for acquisition and asset targeting
  •    Maintained long-standing representation for clients in the agricultural and crop science space
  •    Prosecuted portfolios of patents for Orange Book listings
  •    Represented clients in Inter Partes Reviews and ANDA district court litigations, as well as coordinated European Oppositions with our extensive network of foreign firm

With increasing costs and regulations, the biotechnology and pharmaceutical industry is changing at unprecedented rates. As we move forward, our attorneys are dedicated to building strategic partnerships with our clients so that we effectively understand their needs and help them succeed with their IP goals.

This is how we help our clients. This is our way forward.

Meet our team.

Forward Thinking
September 11, 2015
August 23, 2011
Group Chairs
Chicago, IL
Group Chairs